Ashwini Shami, president and chief portfolio manager at OmniScience Capital, advised investors to remain cautious before committing fresh capital to chemical stocks at current valuations. He also described consumer staples as a classic example of “capital imploders” under the firm’s Scientific Investing Framework, “a feel-good way to lose money”.
On monetary policy, Shami expects both the Reserve Bank of India and the US Federal Reserve to keep interest rates unchanged at their upcoming meetings.